Index -
P/E -
EPS (ttm) -3.18
Insider Own 13.86%
Shs Outstand 34.35M
Perf Week -9.90%
Market Cap 62.52M
Forward P/E -
EPS next Y -1.25
Insider Trans -2.42%
Shs Float 29.59M
Perf Month -35.00%
Enterprise Value 494.81M
PEG -
EPS next Q -0.39
Inst Own 23.50%
Short Float 10.02%
Perf Quarter -15.35%
Income -87.47M
P/S 0.13
EPS this Y 56.95%
Inst Trans -8.55%
Short Ratio 3.66
Perf Half Y -59.82%
Sales 480.40M
P/B 0.40
EPS next Y 30.71%
ROA -11.06%
Short Interest 2.97M
Perf YTD -56.04%
Book/sh 4.59
P/C 3.24
EPS next 5Y 77.23%
ROE -47.95%
52W High 6.48 -71.91%
Perf Year 7.69%
Cash/sh 0.56
P/FCF -
EPS past 3/5Y - -122.90%
ROIC -14.76%
52W Low 1.15 58.26%
Perf 3Y -84.82%
Dividend Est. -
EV/EBITDA 75.54
Sales past 3/5Y 76.27% 62.27%
Gross Margin 10.06%
Volatility 9.98% 12.55%
Perf 5Y -64.03%
Dividend TTM -
EV/Sales 1.03
EPS Y/Y TTM -15.29%
Oper. Margin -10.90%
ATR (14) 0.26
Perf 10Y -12.08%
Dividend Ex-Date -
Quick Ratio 0.93
Sales Y/Y TTM -13.09%
Profit Margin -18.21%
RSI (14) 39.57
Recom 1.67
Dividend Gr. 3/5Y - -
Current Ratio 1.50
EPS Q/Q 76.51%
SMA20 -21.94%
Beta 3.96
Target Price 5.50
Payout -
Debt/Eq 2.86
Sales Q/Q 4.44%
SMA50 -16.23%
Rel Volume 0.46
Prev Close 1.70
Employees 2075
LT Debt/Eq 2.76
Earnings May 07 AMC
SMA200 -36.17%
Avg Volume 809.77K
Price 1.82
IPO Nov 25, 1997
Option/Short Yes / Yes
EPS/Sales Surpr. 30.71% 0.29%
Trades
Volume 371,528
Change 7.06%
Date
Action
Analyst
Rating Change
Price Target Change
May-14-24 Downgrade
Jefferies
Buy → Hold
$11.50 → $3.75
Feb-09-24 Upgrade
Jefferies
Hold → Buy
$3 → $11.50
Jul-20-23 Initiated
Wells Fargo
Overweight
$9
Jan-19-23 Downgrade
Jefferies
Buy → Hold
$10 → $8
Jan-11-23 Upgrade
Lake Street
Hold → Buy
$4 → $10
Nov-18-22 Downgrade
Lake Street
Buy → Hold
$60 → $7
Oct-04-22 Initiated
Jefferies
Buy
$27
Jan-31-22 Initiated
Lake Street
Buy
$60
Sep-20-21 Initiated
Craig Hallum
Buy
$45
May-22-25 04:05PM
May-08-25 03:28AM
12:05AM
12:03AM
May-07-25 06:45PM
04:05PM
Loading…
04:05PM
May-06-25 08:45AM
May-01-25 10:01AM
Apr-30-25 10:01AM
Apr-23-25 04:05PM
(GlobeNewswire) +7.27%
+8.47%
Feb-06-25 02:14AM
Feb-05-25 04:05PM
Jan-22-25 04:05PM
Dec-30-24 04:05PM
Dec-23-24 04:05PM
08:00AM
Loading…
Dec-18-24 08:00AM
Dec-17-24 04:03PM
Dec-04-24 02:00AM
Dec-03-24 04:05PM
Dec-02-24 07:02AM
Nov-21-24 08:30AM
Nov-20-24 04:05PM
Nov-07-24 08:00AM
Oct-09-24 05:54PM
Sep-16-24 08:00AM
Aug-28-24 04:05PM
Aug-08-24 06:15PM
04:05PM
Jul-25-24 08:00AM
Jul-09-24 06:50AM
10:20AM
Loading…
Jul-01-24 10:20AM
Jun-10-24 07:30AM
Jun-03-24 02:49PM
(Associated Press Finance) +16.04%
01:24PM
May-23-24 04:15PM
May-15-24 09:54PM
04:05PM
May-14-24 08:19AM
07:34AM
07:00AM
May-10-24 05:20AM
May-09-24 06:56PM
Apr-29-24 04:05PM
Apr-03-24 08:50AM
Apr-02-24 08:50AM
Mar-25-24 09:40AM
Mar-18-24 08:50AM
Mar-12-24 04:42PM
Mar-07-24 04:20PM
12:00PM
08:50AM
Mar-01-24 09:40AM
Feb-29-24 08:50AM
Feb-27-24 01:34PM
Feb-20-24 07:38AM
Feb-19-24 08:50AM
Feb-14-24 09:40AM
Feb-09-24 08:25AM
Feb-08-24 09:55AM
08:54AM
(Thomson Reuters StreetEvents)
Feb-07-24 06:10PM
04:05PM
Jan-29-24 04:05PM
Jan-27-24 09:00AM
Dec-16-23 03:01PM
Dec-15-23 08:50AM
Dec-14-23 08:14AM
Dec-12-23 07:45AM
(Thomson Reuters StreetEvents) -15.84%
Dec-11-23 09:54PM
04:05PM
Dec-06-23 04:30PM
Nov-27-23 04:05PM
(GlobeNewswire) -13.73%
+6.12%
Nov-13-23 04:05PM
Nov-08-23 07:30AM
Nov-01-23 08:00AM
Oct-16-23 08:00AM
Aug-29-23 06:47PM
Aug-24-23 04:05PM
Aug-15-23 03:31PM
(The Wall Street Journal) -6.86%
Aug-10-23 06:15PM
04:08PM
Jul-24-23 04:35PM
Jul-20-23 08:24PM
Jun-30-23 08:44AM
Jun-05-23 09:55AM
May-30-23 08:50AM
May-25-23 08:33AM
May-19-23 08:33AM
May-18-23 09:55AM
May-13-23 08:15AM
May-11-23 05:55PM
04:05PM
May-08-23 08:18AM
06:27AM
May-04-23 08:33AM
Apr-26-23 08:33AM
Apr-11-23 09:00AM
07:27AM
Mar-24-23 08:38AM
Mar-22-23 03:45AM
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Neff R Matthew Director Jun 02 '25 Sale 2.62 2,000 5,246 153,102 Jun 04 04:05 PM Neff R Matthew Director Jun 02 '25 Proposed Sale 2.60 6,000 15,600 Jun 02 10:26 AM Coelho Mary Theresa Director Apr 01 '25 Sale 2.35 5,500 12,916 74,303 Apr 02 04:32 PM Coelho Mary Theresa Director Apr 01 '25 Proposed Sale 2.83 5,500 15,565 Apr 01 06:33 PM Freeman Jeffrey Brennan VP-Finance & Corp. Controller Feb 18 '25 Sale 4.04 1,339 5,416 27,478 Feb 20 04:34 PM Taylor Beth Chief Financial Officer Feb 18 '25 Sale 4.01 4,370 17,507 108,368 Feb 20 04:33 PM Sagartz John E Chief Strategy Officer Feb 18 '25 Sale 3.94 2,113 8,316 707,816 Feb 20 04:33 PM Leasure Robert Jr. President and CEO Feb 18 '25 Sale 3.82 73,617 281,136 956,592 Feb 20 04:32 PM Leasure Robert Jr. President and CEO Jan 31 '25 Sale 4.15 22,700 94,298 1,030,209 Feb 04 04:15 PM Taylor Beth Chief Financial Officer Jan 31 '25 Sale 4.46 2,054 9,171 112,738 Feb 04 04:14 PM Sagartz John E Chief Strategy Officer Jan 31 '25 Sale 4.48 2,118 9,479 709,929 Feb 04 04:13 PM Krupp Jeffrey Arthur Chief Human Resources Officer Jan 31 '25 Sale 4.48 2,036 9,123 29,029 Feb 04 04:12 PM Krupp Jeffrey Arthur Chief Human Resources Officer Feb 03 '25 Sale 4.18 472 1,973 28,557 Feb 04 04:12 PM Landman David Director Dec 19 '24 Buy 4.25 23,529 99,998 176,851 Dec 23 09:47 PM Beattie John Gregory Chief Operating Officer Dec 10 '24 Buy 4.75 30,000 142,500 161,761 Dec 12 06:46 PM Brown Nigel Director Dec 10 '24 Buy 4.26 7,500 31,950 65,537 Dec 10 04:13 PM Harrington Michael J Director Dec 06 '24 Buy 3.98 10,000 39,822 37,500 Dec 10 08:34 AM Landman David Director Dec 06 '24 Buy 4.14 100,000 414,000 153,322 Dec 10 08:31 AM